You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME/CE

Adherence to Type 2 Diabetes Management Plans: Developing Successful Patient Interactions

  • Authors: Luigi F. Meneghini, MD, MBA; John E. Anderson, MD
  • CME/CE Released: 4/14/2014
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 4/14/2015
Start Activity


Target Audience and Goal Statement

This activity is intended for family and internal medicine physicians, endocrinologists, diabetologists, nurse practitioners, physician assistants, and nurses.

The goal of this activity is to recognize the importance of empathy in fostering physician-patient partnerships, improving patient adherence to therapies for type 2 diabetes (T2D), as well as improving awareness of solutions for overcoming barriers to patient adherence to therapies for T2D.

Upon completion of this activity, participants will be able to:

  1. Propose strategies to build effective clinician-patient partnerships to overcome barriers to treatment adherence in patients with T2D
  2. Identify the importance of empathy in addressing patient concerns that can lead to nonadherence to treatment plans for T2D


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Author(s)

  • Luigi F. Meneghini, MD, MBA

    Professor of Medicine, Division of Endocrinology, University of Texas Southwestern Medical Center, Dallas, Texas

    Disclosures

    Disclosure: Luigi F. Meneghini, MD, MBA, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Boehringer Ingelheim Pharmaceuticals, Inc.; Halozyme Therapeutics; Novo Nordisk; Sanofi;
    Received grants for clinical research from: Boehringer Ingelheim Pharmaceuticals, Inc.; MannKind Corporation; Pfizer Inc; Sanofi

    Dr Meneghini does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Meneghini does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

  • John E. Anderson, MD

    President, The Frist Clinic, Nashville, Tennessee

    Disclosures

    Disclosure: John E. Anderson, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Janssen Pharmaceutical Products, L.P.; Lilly; Sanofi;
    Served as a speaker or a member of a speakers bureau for: AstraZeneca Pharmaceuticals LP; Janssen Pharmaceutical Products, L.P.;

    Dr Anderson does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Anderson does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editors

  • Anne G. Le, PharmD, RPh

    Lead Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Anne G. Le, PharmD, RPh, has disclosed no relevant financial relationships.

  • Karen Badal, MD, MPH

    Associate Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Karen Badal, MD, MPH, has disclosed no relevant financial relationships.

CME Reviewer(s)

  • Nafeez Zawahir, MD

    CME Clinical Director, Medscape, LLC

    Disclosures

    Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

Nurse Planner

  • Amy Bernard, MS, BSN, RN-BC

    Lead Nurse Planner, Medscape, LLC

    Disclosures

    Disclosure: Amy Bernard, MS, BSN, RN-BC, has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Medscape, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    Contact This Provider

    For Nurses

  • Medscape, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    Awarded 0.75 contact hour(s) of continuing nursing education for RNs and APNs; 0.75 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME/CE

Adherence to Type 2 Diabetes Management Plans: Developing Successful Patient Interactions

Authors: Luigi F. Meneghini, MD, MBA; John E. Anderson, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME/CE Released: 4/14/2014

Valid for credit through: 4/14/2015

processing....

This feature requires the newest version of Flash. You can download it here.
  • Print